BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 21385286)

  • 1. The impact of young age on outcomes in esophageal and junctional cancer.
    Donohoe CL; MacGillycuddy E; Reynolds JV
    Dis Esophagus; 2011 Nov; 24(8):560-8. PubMed ID: 21385286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolving progress in oncologic and operative outcomes for esophageal and junctional cancer: lessons from the experience of a high-volume center.
    Reynolds JV; Donohoe CL; McGillycuddy E; Ravi N; O'Toole D; O'Byrne K; Hollywood D
    J Thorac Cardiovasc Surg; 2012 May; 143(5):1130-1137.e1. PubMed ID: 22244551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical T2-T3N0M0 esophageal cancer: the risk of node positive disease.
    Stiles BM; Mirza F; Coppolino A; Port JL; Lee PC; Paul S; Altorki NK
    Ann Thorac Surg; 2011 Aug; 92(2):491-6; discussion 496-8. PubMed ID: 21704291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival in Patients With Esophageal Adenocarcinoma Undergoing Trimodality Therapy Is Independent of Regional Lymph Node Location.
    Sepesi B; Schmidt HE; Lada M; Correa AM; Walsh GL; Mehran RJ; Rice DC; Roth JA; Vaporciyan AA; Ajani JA; Watson TJ; Swisher SG; Low DE; Hofstetter WL
    Ann Thorac Surg; 2016 Mar; 101(3):1075-80; Discussion 1080-1. PubMed ID: 26680311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment and outcome of young patients with esophageal cancer in the Netherlands.
    van Nistelrooij AM; van Steenbergen LN; Spaander MC; Tilanus HW; van Lanschot JJ; Lemmens VE; Wijnhoven BP
    J Surg Oncol; 2014 May; 109(6):561-6. PubMed ID: 24338660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment strategies in recurrent esophageal or junctional cancer.
    Butter R; Lagarde SM; van Oijen MGH; Anderegg MCJ; Gisbertz SS; Meijer SL; Hulshof MCCM; Bergman JJGHM; van Berge Henegouwen MI; van Laarhoven HWM
    Dis Esophagus; 2017 Sep; 30(9):1-9. PubMed ID: 28859371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multifocal neoplasia and nodal metastases in T1 esophageal carcinoma: implications for endoscopic treatment.
    Altorki NK; Lee PC; Liss Y; Meherally D; Korst RJ; Christos P; Mazumdar M; Port JL
    Ann Surg; 2008 Mar; 247(3):434-9. PubMed ID: 18376186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of patients with cancer of the esophagogastric junction in relation to histology and surgical strategy.
    Gianotti L; Braga M; Landoni L; Mari G; Scaltrini F; Di Castelnuovo A; Di Carlo V
    Hepatogastroenterology; 2003; 50(54):1948-52. PubMed ID: 14696439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I/II trial of preoperative oxaliplatin, docetaxel, and capecitabine with concurrent radiation therapy in localized carcinoma of the esophagus or gastroesophageal junction.
    Spigel DR; Greco FA; Meluch AA; Lane CM; Farley C; Gray JR; Clark BL; Burris HA; Hainsworth JD
    J Clin Oncol; 2010 May; 28(13):2213-9. PubMed ID: 20351330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival after esophageal resection for carcinoma: the importance of the histologic cell type.
    Alexiou C; Khan OA; Black E; Field ML; Onyeaka P; Beggs L; Duffy JP; Beggs DF
    Ann Thorac Surg; 2006 Sep; 82(3):1073-7. PubMed ID: 16928541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and topography of lymph node metastases in early esophageal and gastric cancer.
    Gertler R; Stein HJ; Schuster T; Rondak IC; Höfler H; Feith M
    Ann Surg; 2014 Jan; 259(1):96-101. PubMed ID: 24096772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome after esophagectomy for cancer of the esophagus and GEJ in patients aged over 75 years.
    Internullo E; Moons J; Nafteux P; Coosemans W; Decker G; De Leyn P; Van Raemdonck D; Lerut T
    Eur J Cardiothorac Surg; 2008 Jun; 33(6):1096-104. PubMed ID: 18407509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of number and site of lymph node invasion on survival of adenocarcinoma of esophagogastric junction.
    Ielpo B; Pernaute AS; Elia S; Buonomo OC; Valladares LD; Aguirre EP; Petrella G; Garcia AT
    Interact Cardiovasc Thorac Surg; 2010 May; 10(5):704-8. PubMed ID: 20154347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis of the survival in patients after surgical resection of thoracic esophageal cancer].
    Zhang HL; Liu RL; Shi YT; Wang ZC; Wang BH; Li YJ; Zhou LY; Ping YM
    Zhonghua Zhong Liu Za Zhi; 2009 Jul; 31(7):541-5. PubMed ID: 19950705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defining a positive circumferential resection margin in oesophageal cancer and its implications for adjuvant treatment.
    O'Neill JR; Stephens NA; Save V; Kamel HM; Phillips HA; Driscoll PJ; Paterson-Brown S
    Br J Surg; 2013 Jul; 100(8):1055-63. PubMed ID: 23616367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Surgery of esophageal cancer in Liège. II. Analysis of factors influencing long-term survival after esophagectomy for epidermoid cancer or adenocarcinoma].
    Kolh P; Honoré P; Degauque C; Azzam C; Gielen JL; Legrand M; Dewé W; Jacquet N
    Rev Med Liege; 1998 Jun; 53(6):363-9. PubMed ID: 9713218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic impact of preoperative platelets to lymphocytes ratio (PLR) on survival for oesophageal and junctional carcinoma treated with neoadjuvant chemotherapy: A retrospective monocentric study on 153 patients.
    Messager M; Neofytou K; Chaudry MA; Allum WH
    Eur J Surg Oncol; 2015 Oct; 41(10):1316-23. PubMed ID: 26166786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of long-term survival after resection of esophageal carcinoma with nonregional nodal metastases.
    Lee PC; Port JL; Paul S; Stiles BM; Altorki NK
    Ann Thorac Surg; 2009 Jul; 88(1):186-92; discussion 192-3. PubMed ID: 19559222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can extracapsular lymph node involvement be a tool to fine-tune pN1 for adenocarcinoma of the oesophagus and gastro-oesophageal junction in the Union Internationale contre le Cancer (UICC) TNM 7th edition?†.
    Nafteux P; Lerut T; De Hertogh G; Moons J; Coosemans W; Decker G; Van Veer H; De Leyn P
    Eur J Cardiothorac Surg; 2014 Jun; 45(6):1001-10. PubMed ID: 24477743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Classification of pathologic response to neoadjuvant therapy in esophageal and junctional cancer: assessment of existing measures and proposal of a novel 3-point standard.
    Donohoe CL; O'Farrell NJ; Grant T; King S; Clarke L; Muldoon C; Reynolds JV
    Ann Surg; 2013 Nov; 258(5):784-92; discussion 792. PubMed ID: 24045450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.